Create an account to save your articles and sync them across devices
bloomberg.com • Pharmaceuticals • Spain
Spain's success in attracting significant pharmaceutical investment from major companies like AstraZeneca, Novartis, and Roche contrasts with Europe's broader struggles in the sector.
chicagotribune.com • Pharmaceuticals • United States
The article examines the controversial practice of direct-to-consumer drug advertising in the United States, exploring its impact on healthcare costs, patient decision-making, and the ethical considerations involved.
bbc.com • Pharmaceuticals • World
A BBC investigation reveals an Indian pharmaceutical company illegally exports highly addictive opioids to West Africa, fueling a major public health crisis.
cnn.com • Pharmaceuticals • World
Pfizer halted development of its potential daily obesity pill, danuglipron, due to a trial participant experiencing a possible drug-induced liver injury.
elpais.com • Pharmaceuticals • Spain
Spain's high generic drug prices compared to other European countries, particularly Scandinavia, are prompting government action to lower costs and ensure continued domestic production.
irishtimes.com • Pharmaceuticals • Ireland
A survey by the Irish Pharmacy Union reveals that Irish pharmacists are facing increased workloads due to widespread medicine shortages, impacting patient care and requiring urgent systemic solutions.
forbes.com • Pharmaceuticals • World
Pfizer's deal with Ranbaxy extends the market exclusivity of Lipitor, delaying the entry of generic versions and securing billions in additional revenue.
dailymail.co.uk • Pharmaceuticals • USA
A former pharmaceutical sales representative's undercover work exposed alleged illegal practices at Questcor Pharmaceuticals, leading to a multi-million dollar settlement.
linkedin.com • Pharmaceuticals • Spain
ManpowerGroup Talent Solutions is seeking a Quality Project Analysis Specialist for a multinational pharmaceutical company in Martorelles, Catalonia.
livemint.com • Pharmaceuticals • India
Indian drugmakers Natco Pharma and Dr Reddy's are suing Novo Nordisk over its blockbuster anti-obesity drug, semaglutide, aiming to launch cheaper generic versions before the patent expires, fueled by the lucrative Indian market.